Vireo Growth (VREOF) Change in Intangibles (2022)

Vireo Growth (VREOF) reported Change in Intangibles of $236635.0 for Q1 2022.

Vireo Growth (VREOF) Change in Intangibles (2022) Analysis & Trends

Vireo Growth (VREOF) has 1 years of Change in Intangibles data on file, last reported at $236635.0 in Q1 2022.

  • For the quarter ending Q1 2022, Change in Intangibles changed N/A year-over-year to $236635.0; the trailing twelve-month figure through Dec 2022 stood at $236635.0 (changed N/A YoY), and the FY2022 full-year result was $236635.0, changed N/A from the prior year.
  • Change in Intangibles steadied at $236635.0 in Q1 2022.
  • In the past five years, Change in Intangibles ranged from a high of $236635.0 in Q1 2022 to a low of $236635.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -107.94 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 236,635.00
Mar 31, 2022 236,635.00